<DOC>
	<DOCNO>NCT01313039</DOCNO>
	<brief_summary>If AZD6244 able increase ER expression ER-negative/low cancer may possible effectively use hormonal therapy patient result improved outcome . The investigator propose single-arm Simon two-step study examine whether treatment AZD6244 result increase ER expression ER-negative/low primary breast tumor .</brief_summary>
	<brief_title>Evaluation Use AZD6244 Induce Increased ER Expression Anti-Estrogen Response ER-Negative/Low Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estrogen Receptor Modulators</mesh_term>
	<mesh_term>Estrogen Antagonists</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Female breast cancer patient &gt; 18 year . Patients must biopsyproven clinical Stage IcIII invasive breast carcinoma â‰¤ 10 % ER expression immunohistochemistry ( IHC ) analysis . Patients must pretreatment baseline core biopsy incisional biopsy available additional testing ( ER , protein/gene expression analysis ) . Patients must sufficient tumor remain follow diagnostic biopsy require additional definitive surgical procedure per standard care . Planned procedure may include lumpectomy mastectomy clinically indicate . Patients must ECOG Performance Status 0 1 . Patients must ability understand willingness sign English Spanish language write informed consent document . Male breast cancer patient . Patients pregnant breastfeed exclude study due potential harm fetus nursing infant study therapy . Patients reproductive potential must consent use contraception abstinence eligible study . Patients may receive prior chemotherapy hormonal therapy treatment current breast cancer . Patients know strongly suspect BRCA mutation history ( genetic testing require ) . Patients prestudy test , include history physical exam , complete blood count , measurement renal hepatic function . Patients ineligible study significant abnormality detect , accordance good medical practice .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>ER-negative</keyword>
	<keyword>Allred Score</keyword>
</DOC>